<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2022v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-11-15T09:59:32-06:00</ReturnTs>
    <TaxPeriodEndDt>2022-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>362985770</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>SELDEN FOX LTD</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>ONE PARKVIEW PLAZA SUITE 710</AddressLine1Txt>
        <CityNm>OAKBROOK TERRACE</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60181</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2022-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>770671561</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>AMERICAN SOCIETY FOR DERMATOLOGIC</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>SURGERY</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>8479560900</PhoneNum>
      <USAddress>
        <AddressLine1Txt>1933 N MEACHAM ROAD 650</AddressLine1Txt>
        <CityNm>SCHAUMBURG</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60173</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KATHERINE J DUERDOTH</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>8479560900</PhoneNum>
      <SignatureDt>2023-11-13</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>KATHERINE</PersonFirstNm>
        <PersonLastNm>DUERDOTH</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>0</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>STEVEN G PIERSON</PreparerPersonNm>
      <PTIN>P00653362</PTIN>
      <PhoneNum>6309541400</PhoneNum>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>2</TrustedCustomerCd>
        <AuthenticationAssuranceLevelCd>AAL1</AuthenticationAssuranceLevelCd>
        <IdentityAssuranceLevelCd>IAL1</IdentityAssuranceLevelCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2022</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <AddressChangeInd>X</AddressChangeInd>
      <PrincipalOfficerNm>KATHERINE J DUERDOTH</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>1933 N MEACHAM ROAD 650</AddressLine1Txt>
        <CityNm>SCHAUMBURG</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60173</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>8209517</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ASDS.NET</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1973</FormationYr>
      <LegalDomicileStateCd>IL</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE PURPOSES OF THE SOCIETY SHALL BE TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP AND ENCOURAGE INVESTIGATIVE KNOWLEDGE IN DERMATOLOGIC SURGERY; TO PROMOTE THE HIGHEST POSSIBLE STANDARDS IN CLINICAL PRACTICE, CONTINUING EDUCATION AND RESEARCH IN DERMATOLOGIC SURGERY; TO PROMOTE THE HIGHEST STANDARDS OF PATIENT CARE AND PROMOTE THE PUBLIC INTEREST RELATING TO DERMATOLOGIC SURGERY AND TO PROVIDE A FORUM FOR THE EXCHANGE OF IDEAS AND METHODOLGY FOR DERMATOLOGIC SURGERY AND RELATED BASIS SCIENCES.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>15</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>15</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>24</TotalEmployeeCnt>
      <TotalVolunteersCnt>635</TotalVolunteersCnt>
      <TotalGrossUBIAmt>43134</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>38132</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>2524666</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>2127047</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>2227201</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>3193726</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1037223</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>-771421</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>893838</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>895719</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>6682928</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>5445071</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>0</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>232500</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>1750550</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1711451</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>621325</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>2569089</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>3373316</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>4319639</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>5317267</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>2363289</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>127804</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>16635665</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>13611431</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>2170975</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>1215611</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>14464690</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>12395820</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE PURPOSES OF THE SOCIETY SHALL BE TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP AND ENCOURAGE INVESTIGATIVE KNOWLEDGE IN DERMATOLOGIC SURGERY; TO PROMOTE THE HIGHEST POSSIBLE STANDARDS IN CLINICAL PRACTICE, CONTINUING EDUCATION AND RESEARCH IN DERMATOLOGIC SURGERY; TO PROMOTE THE HIGHEST STANDARDS OF PATIENT CARE AND PROMOTE THE PUBLIC INTEREST RELATING TO DERMATOLOGIC SURGERY AND TO PROVIDE A FORUM FOR THE EXCHANGE OF IDEAS AND METHODOLGY FOR DERMATOLOGIC SURGERY AND RELATED BASIS SCIENCES.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>232500</ExpenseAmt>
      <GrantAmt>232500</GrantAmt>
      <Desc>THE SOCIETY SUPPORTS RESEARCH BY PROVIDING GRANTS TO QUALIFIED MEMBERS THROUGH THE CUTTING EDGE RESEARCH GRANT PROGRAM. THE GOAL OF THE PROGRAM IS TO ENCOURAGE RESEARCH IN AREAS OF SPECIFIC RELEVANCE TO COSMETIC/GENERAL DERMATOLOGIC SURGERY SUCH AS LASERS, LIPOSUCTION, FILLERS, RESURFACING, LIFTING PROCEDURES, AND CUTANEOUS ONCOLOGY. IN ADDITION, ASDS IS NOW FUNDING BOARD DIRECTED RESEARCH THAT ADDRESSES VALUE-BASED HEALTHCARE, PATIENT SATISFACTION, AND COST CONTAINMENT.FREDRIC S. BRANDT, MD INNOVATIONS IN AESTHETICS FELLOWSHIP FUND:THE BRANDT FUND GRANTS FELLOWS-IN-TRAINING FUNDS TO UNDERTAKE INNOVATIVE RESEARCH PROPOSALS RELATED TO COSMETIC DERMATOLOGY IN HONOR OF THE LATE FREDRIC BRANDT, MD. YOUNG INVESTIGATOR'S WRITING COMPETITION:THE YOUNG INVESTIGATOR'S WRITING COMPETITION IS A PROGRAM THAT RECOGNIZES YOUNG INVESTIGATORS FOR THEIR ORIGINAL IDEAS, RESEARCH AND ARTICLES FOR PUBLICATION IN ACADEMIC, PEER REVIEWED JOURNALS, SUCH AS DERMATOLOGIC SURGERY. REVIEW ARTICLE INCENTIVE PROGRAM:THE REVIEW ARTICLE INCENTIVE PROGRAM WAS DEVELOPED TO INCREASE THE NUMBER OF REVIEW ARTICLES IN DERMATOLOGIC SURGERY ON TOPICS OF BROAD SCIENTIFIC INTEREST OR HIGHLY FOCUSED CLINICAL TOPICS RELATED TO THERAPY, DIAGNOSIS OR OTHER ASPECTS OF DERMATOLOGIC SURGERY PRACTICE.THESE ACTIVITIES SUPPORT OUR RESEARCH GOALS. DURING 2020 THE SOCIETY SUSPENDED MANY OF THESE ACTIVITIES DUE TO THE COVID-19 PANDEMIC. THESE ACTIVITIES HAVE RESUMED IN 2021.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>2416616</ExpenseAmt>
        <RevenueAmt>1263873</RevenueAmt>
        <Desc>LEADERSHIP:FUTURE LEADERS NETWORK:THE FUTURE LEADERS NETWORK WAS CREATED TO HELP ASDS AND THE SPECIALTY MEET ITS CURRENT AND FUTURE CHALLENGES. THROUGH THIS PROGRAM, ASDS PROVIDES AN AVENUE FOR YOUNG LEADERS TO WORK WITH EXPERIENCED MENTORS ON PROJECTS THAT WILL BENEFIT THE ASDS AND ITS MEMBERS WHILE THEY FINE-TUNE THEIR LEADERSHIP SKILLS. OUR GOAL IS TO DEVELOP A POOL OF TRAINED LEADERS WHO CAN CARRY ON THE TRADITION OF EXCELLENCE IN OUR SPECIALTY AND ALLOW US TO REACH NEW HEIGHTS. EACH YEAR THE ASDS PROVIDES FUNDING TO SUPPORT 5 - 10 MENTOR/MENTEE PAIRS.PARTNERS IN PROFESSIONAL DEVELOPMENT:THE PROGRAM IS DESIGNED TO ASSIST YOUNG DERMATOLOGIC SURGEONS WITH THE ADVICE AND INSIGHTS THEY NEED TO BUILD A SUCCESSFUL CAREER AND/OR PRACTICE. THE PARTNERS IN PROFESSIONAL DEVELOPMENT PROGRAM WILL SERVE AS A MENTORSHIP IN PRACTICE MANAGEMENT AND RELATED CAREER-BUILDING ACTIVITIES. THE GOAL OF THE PROGRAM IS TO FOSTER PROFESSIONAL DEVELOPMENT FOR YOUNG DERMATOLOGIC SURGEONS WHO ARE IN THE FIRST FIVE YEARS OF THEIR CAREER. MENTEES WILL BE PAIRED WITH A MENTOR FOR ONE YEAR IF DESIRED, AND MENTORS MAY CHOOSE TO WORK WITH A MENTEE WITHIN OR BEYOND THEIR GEOGRAPHIC AREA. MENTORS AND MENTEES ARE ENCOURAGED TO DISCUSS RELEVANT TOPICS AT LEAST QUARTERLY. AREAS FOR MENTORSHIP INCLUDE PRACTICE MANAGEMENT, PUBLIC EDUCATION, PROFESSIONAL SOCIETY LEADERSHIP AND PUBLIC SPEAKING.LEGACY CIRCLEASDS LAUNCHED THE NEW MEMBER DONATION PROGRAM--THE LEGACY CIRCLE WEBSITE PORTAL. THE PORTAL WILL ALLOW ASDS MEMBERS SEVERAL DIFFERENT OPPORTUNITIES TO GIVE IN THE PRESENT (STEGMAN CIRCLES) AND FUTURE (LEGACY CIRCLE). THE LEGACY CIRCLE GIVING PROGRAM IS THE FIRST PLANNED GIVING PROGRAM OF ASDS. PHYSICIAN EDUCATION: THE SOCIETY IS AN ORGANIZATION WHOSE PRIMARY PURPOSE IS TO PROMOTE OPTIMAL QUALITY CARE FOR PATIENTS AS WELL AS TO SUPPORT AND DEVELOP INVESTIGATIVE KNOWLEDGE IN THE FIELD OF DERMATOLOGIC SURGERY.ACCME RE-ACCREDITATION:IN 2014, ASDS RECEIVED REACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION FOR CONTINUING MEDICAL EDUCATION (ACCME) GRANTING IT ACCREDITATION FOR SIX INSTEAD OF FOUR YEARS. THIS IS THE HIGHEST LEVEL OF RECOGNITION AWARDED BY THE ACCME, TO ONLY ABOUT 21 PERCENT OF ACCREDITED CME PROVIDERS. ASDS IS UP FOR REVIEW IN 2020.ANNUAL MEETING:OUR ANNUAL MEETING CONTINUES TO BE THE DEFINITIVE EDUCATIONAL EXPERIENCE FOR DERMATOLOGIC SURGEONS WITH OVER 1300 PHYSICIAN ATTENDEES LEARNING ABOUT THE FULL SCOPE OF PRACTICE OF COSMETIC AND SURGICAL DERMATOLOGY. THE ANNUAL MEETING ALSO INCLUDED A TRADESHOW OFFERING COMPANIES THE OPPORTUNITY TO DISSEMINATE THE LATEST INFORMATION ON THEIR PRODUCTS AND SERVICES TO ATTENDEES. FUNDING FOR THE ANNUAL MEETING IS GENERATED BY ATTENDEE REGISTRATION FEES, CORPORATE SPONSORSHIP, ADVERTISING AND EXHIBIT SHOW APPLICATION FEES.DRS. ALATASIR AND JEAN CARRUTHERS AWARD IN HONOR OF DRS. ALASTAIR AND JEAN CARRUTHERS, THE CARRUTHERS AWARD WAS CREATED TO STIMULATE INTEREST AND ACKNOWLEDGE COSMETIC RESEARCH CONTRIBUTIONS FROM MEMBERS OF ASDS-ACCREDITED FELLOWSHIP TRAINING PROGRAMS. THE AWARD IS PRESENTED TO THE HIGHEST SCORING ABSTRACT FOR WHICH A FELLOW IS THE FIRST AUTHOR.PRECEPTORSHIP PROGRAM:THE PRECEPTORSHIP PROGRAM PROVIDES AN UNCONVENTIONAL LEARNING ENVIRONMENT TO PERFECT SKILLS IN THOSE AREAS OF THE SPECIALTY OF DERMATOLOGIC SURGERY WHERE INNOVATION HAS OUTPACED TRADITIONAL TRAINING PROGRAMS. THE PROGRAM PROVIDES PHYSICIANS THE OPPORTUNITY TO LEARN FROM SEASONED EXPERTS BY SPENDING A MINIMUM OF ONE WEEK IN THEIR OFFICE OBSERVING PROCEDURES AND LEARNING ABOUT VARIOUS ASPECTS OF THE PRACTICE. THE PRECEPTORSHIP PROGRAM RECEIVES CORPORATE FUNDING BY WAY OF AN UNRESTRICTED GRANT. THIS PRECEPTORSHIP PROGRAM FURTHERS OUR EDUCATION GOALS.LAWRENCE M. FIELD, MD INTERNATIONAL DERMATOLOGIC SURGERY MENTORSHIP EXCHANGE FUND:THE ASDS INTERNATIONAL TRAVELING MENTORSHIP PROGRAM (ITMP) ENHANCES THE EXCHANGE OF INFORMATION AND BODY OF KNOWLEDGE OF DERMATOLOGIC SURGERY AMONG THE INTERNATIONAL COMMUNITY OF DERMATOLOGIC SURGEONS. IT PRIMARILY FOCUSES ON TEACHING PROGRAMS AND DERMATOLOGIC FACULTY AND ALLOWS DERMATOLOGIC SURGEONS TO VISIT A HOST INSTITUTION IN ANOTHER COUNTRY AS MENTORS - OR HOST A DERMATOLOGIC SURGEON TRAVELING MENTOR FROM ANOTHER COUNTRY - FOR A DEFINED PERIOD OF TEACHING, SURGICAL DEMONSTRATION AND TABLE-SIDE EXCHANGE. PARTICIPANTS ARE SELECTED ON A SEMI-ANNUAL BASIS AT A MINIMUM. LIMITED FUNDING IS AVAILABLE. ESTABLISHED THROUGH THE LAWRENCE FIELD, MD, INTERNATIONAL DERMATOLOGIC SURGERY EDUCATIONAL EXCHANGE FUND.INTERNATIONAL PRECEPTORSHIP PROGRAM:THIS PROGRAM ASSISTS INTERNATIONAL DERMATOLOGIC SURGEONS IN VISITING A PRECEPTOR IN THE U.S. TO EXPAND THEIR KNOWLEDGE OF PROCEDURES AND ADVANCED TECHNIQUES NOT AVAILABLE IN THEIR COUNTRY OF ORIGIN. THIS KNOWLEDGE IS SHARED WITH COLLEAGUES, HELPING TO ADVANCE PATIENT CARE IN THEIR HOME COUNTRY. AVAILABLE TO ASDS MEMBERS (AND MEMBERS OF OTHER INTERNATIONAL SOCIETIES BASED ON WORK GROUP APPROVAL). THERE IS ONE INTERNATIONAL DERMATOLOGIST SELECTED ANNUALLY TO PARTICIPATE IN THIS PROGRAM. LIMITED FUNDING IS AVAILABLE. ESTABLISHED THROUGH THE LAWRENCE FIELD, MD, INTERNATIONAL DERMATOLOGIC SURGERY EDUCATIONAL EXCHANGE FUND. RISE UP MENTORSHIP PROGRAMTHE DIVERSITY, EQUITY AND INCLUSION WORK GROUP CONTINUES TO ADVANCE INITIATIVES THAT PROMOTE INCLUSION OF PEOPLE OF COLOR, LGBTQ, AND OTHER GROUPS UNDERREPRESENTED IN MEDICINE; AND TO PROMOTE EQUITY AND WITHIN ASDS AND ACROSS OUR FIELD. THIS RISE UP MENTORSHIP PROGRAM MATCHES MENTORS AND MENTEES UNDERREPRESENTED IN MEDICINE FOR A YEAR-LONG MENTORSHIP PROGRAM. THEY IDENTIFY A COMMON GOAL FOR THE MENTEE TO ACHIEVE BY THE END OF THE CALENDAR YEAR.SURGICAL DIRECTORS FORUM:THE SURGICAL DIRECTORS MEET REGULARLY TO IDENTIFY AREAS OF COMMON CONCERN, INCLUDING COSMETIC TRAINING IN RESIDENCY PROGRAMS, BEST PRACTICES FOR COSMETIC STUDIES, COLLABORATIVE RESEARCH, AND PRACTICAL GUIDELINES AND ISSUES. THE GROUP FOCUSES ON COLLABORATIVE RESEARCH AND PROCEDURAL TRAINING IN RESIDENCY PROGRAMS, AS WELL AS REGULATORY ISSUES AFFECTING THEIR INSTITUTIONAL PRACTICES. COSMETIC DERMATOLOGIC SURGERY FELLOWSHIP TRAINING PROGRAM ACCREDITATION:ASDS ACCREDITS COSMETIC DERMATOLOGIC SURGERY FELLOWSHIP TRAINING PROGRAMS. THE PURPOSE OF THE PROGRAM IS TO CONFIRM AND RECOGNIZE THE COSMETIC DERMATOLOGIC SURGERY FELLOWSHIP PROGRAMS THAT MEET HIGH QUALITY STANDARDS AND PROMOTE PRACTICES THAT PROVIDE FELLOWS WITH THE PROPER TRAINING AND EXPERTISE TO PERFORM COSMETIC DERMATOLOGIC SURGERY PROCEDURES. TO DATE, 19 PROGRAMS HAVE BEEN ACCREDITED.ASDS LEARNASDS LEARN EDUCATIONAL ACTIVITIESTHE NEW ASDS LEARN RE-DESIGN WITH IMPROVED VISUAL DESIGN AND ORGANIZATION STRUCTURE BASED ON EDUCATIONAL TRACKS AND CONTENT HAS BEEN COMPLETED. WE WILL BE ADDING ADDITIONAL NEW PRE-RECORDED CONTENT AS WELL AS ALL PUBLICATIONS WILL BE AVAILABLE THRU ASDS LEARN FOR DIGITAL DOWNLOAD. WE PLAN TO LAUNCH THIS AT THE ANNUAL MEETING. TOP 5 VISITED COURSES:4,553 TOTAL USERS/347 ACTIVE USERS THIS MONTH1.MICROGRAPHIC DERMATOLOGIC SURGERY (MDS) EXAM REVIEW: 6386 VISITS (62.31%)2.RESQ PROCEDURAL DERMATOLOGY REVIEW : 1284 VISITS (12.53%)3.VIRTUAL PROFESSOR LECTURES FOR RESIDENTS AND FELLOWS IN TRAINING: 608 VISITS (5.93%)4.COSMETIC STRUCTURED DIDACTICS: 546 VISITS (5.33%)5.2021 ANNUAL MEETING CME CLAIM: 382 VISITS (3.73%)TOTAL LEARN REVENUE AS OF 9/29 - $40, 2752022 WEBINARS UPDATEFOUR CLINICAL WEBINARS AND ONE ADVOCACY WEBINAR HAVE TAKEN PLACE THUS FAR IN 2022; ALL LIVE PLUS ON-DEMAND VIEWING IS AVAILABLE. - TISSUE MICROCORING - MARCH 11; 25 ATTENDED- ACNE SCAR PROCEDURES - MAY 3; 32 ATTENDED - IMMUNOTHERAPY FOR NON-MELANOMA SKIN CANCER - JUNE 2, 2022; 4 ATTENDED- NON-SURGICAL APPROACHES TO FIELD CANCERIZATION PATIENTS; 1 ATTENDED- ASDSA CODING WEBINAR - 11 ATTENDEDMICROGRAPHIC DERMATOLOGIC SURGERY (MDS) SUBSPECIALTY CERTIFICATION EXAM REVIEW COURSETHE ONLINE, ON-DEMAND 10 MODULE COURSE DEVELOPED BY 27 FACULTY IN 2020 AS A STUDY GUIDE FOR THE MICROGRAPHIC DERMATOLOGIC SURGERY (MDS) SUBSPECIALTY CERTIFICATION EXAMINATION IS AVAILABLE AND BEING PROMOTED / SOLD. THE PATHOLOGY WEBINAR IS BEING OFFERED AS BONUS CONTENT WITH PURCHASE. CURRENT SALES FOR 2022 IS 127, RESULTING IN $31,000 IN REVENUE.PART III, QUESTION 4B IS CONTINUED BELOW</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>818737</ExpenseAmt>
        <RevenueAmt>1870506</RevenueAmt>
        <Desc>DERMATOLOGIC SURGERY JOURNAL:THE SOCIETY PRODUCES A MONTHLY SCIENTIFIC JOURNAL ON THE LATEST TECHNOLOGICAL ADVANCES AND SCIENTIFIC BREAKTHROUGHS. THE MONTHLY CIRCULATION OF DERMATOLOGIC SURGERY IS ROUGHLY 8,000 IN THE DERMATOLOGIC FIELD. THE JOURNAL ADVANCES OUR PURPOSE OF PROVIDING CLINICAL EDUCATION FOR PHYSICIANS ON DERMATOLOGIC SURGERY. FUNDING FOR THIS ACTIVITY IS THROUGH MEMBER DUES.THIS YEAR, DR. NAOMI LAWRENCE LAUNCHED "DERMSURGERY DIGEST," A NEW JOURNAL PODCAST FEATURING A SUMMARY OF ALL ARTICLES INCLUDED IN EACH ISSUE. THIS PROVIDES AN AUDITORY OPTION TO STAY UP TO DATE ON THE LATEST RESEARCH. THIS PODCAST IS AVAILABLE ON SPOTIFY, APPLE AND GOOGLE PODCASTS. YOU CAN ALSO ACCESS ALL EPISODES ON ASDS LEARN. CURRENTS:THE SOCIETY OFFERS ITS MEMBERS A QUARTERLY NEWSLETTER, CURRENTS, TO COMMUNICATE SOCIOECONOMIC, CLINICAL AND SOCIETY-SPECIFIC ISSUES TO ITS MEMBERSHIP. THE NEWSLETTER COVERS MEMBER AND SOCIETY NEWS, EDUCATIONAL ARTICLES ON SUBJECTS OF INTEREST TO MEMBERS, AND UPDATES ON ISSUES IMPACTING THE DERMATOLOGY COMMUNITY. CURRENTS IS A MEMBER SERVICE PROVIDED AS A BENEFIT OF DUES, BUT IS AVAILABLE TO NON-MEMBERS ON A SUBSCRIPTION BASIS. CORPORATE SUPPORT OFFSETS A PORTION OF RELATED EXPENSES TO PUBLISH THIS MAGAZINE.ACHIEVE:ACHIEVE IS THE ANNUAL REPORT OF THE SOCIETY AND ASSOCIATION WHICH PROVIDES MEMBERS WITH A SNAPSHOT OF THE HIGHLIGHTS OF THE YEAR.BRANDINGTHE SOCIETY'S NATIONAL BRANDING CAMPAIGN PROMOTES ASDS MEMBERS AS THE TRUE SKIN HEALTH AND BEAUTY EXPERTS, DRIVING TRAFFIC TO THE ASDS WEBSITE'S REFERRAL SERVICE. BRANDING CAMPAIGNS INCLUDE ONGOING SOCIAL MEDIA POSTS; EMAILS TO MEMBERSHIP ENCOURAGING PUBLIC SERVICE PROGRAM PARTICIPATION AND SOCIAL MEDIA ENGAGEMENT; CONSUMER-FACING WEBSITE CONTENT UPDATES; MEDIA RELATIONS OUTREACH; AND EDITORIAL PRINT COVERAGE IN VARIOUS PUBLICATIONS.SOCIAL MEDIATHE SOCIETY'S SOCIAL MEDIA CHANNELS CONTINUE TO BE AN EFFECTIVE MEANS OF COMMUNICATION IN PROVIDING MEMBERS AND CONSUMERS WITH TIMELY, ENGAGING AND EDUCATIONAL CONTENT THUS FAR IN 2022. THE SOCIETY'S HANDLES AND HASHTAGS ARE BASED ON THE CONTENT'S TARGET AUDIENCE:- @ASDSMEMBERS - #ASDSMEMBERS #ASDSRESIDENTS #ASDSMEETING #ASDSDIVERSITY #ASDSAMBASSADOR #ASDSSKINEXPERTS - @ASDSSKINMD - #ASDSSKINMD #ASDSDIVERSITY #ASDSSKINEXPERTS #ASDSAMBASSADOR- @ASDSADVOCACY - #ASDSADVOCACY #SUNUCATE"OWN YOUR EXPERTISE" CAMPAIGNTHE "OWN YOUR EXPERTISE" SOCIAL MEDIA CAMPAIGN HIGHLIGHTS ASDS/A MEMBERS' LONGSTANDING HISTORY OF INNOVATION FOR AESTHETIC AND COSMETIC PROCEDURES AND EDUCATES CONSUMERS ON WHY THEY SHOULD ONLY TRUST A BOARD CERTIFIED ASDS MEMBER WITH THEIR DERMATOLOGIC PROCEDURES. THESE CONSUMER-FACING ASDS SKIN MD POSTS ARE SHARED WITH MEMBERS MONTHLY TO ENCOURAGE RESHARING ACROSS THEIR PERSONAL OR PRACTICE SOCIAL MEDIA NETWORKS TO GROW SOCIAL MEDIA IMPRESSIONS..THE TRUE SKIN EXPERTS LIVETO ENHANCE THE "OWN YOUR EXPERTISE" CAMPAIGN, THE SOCIETY LAUNCHED AN INSTAGRAM LIVE SERIES, THE TRUE SKIN EXPERTS LIVE, TO SHARE ASDS MEMBER EXPERTISE WHILE ALSO SHOWCASING THE PERSONALITY OF ASDS MEMBERSHIP, HUMANIZING THE PHYSICIAN IN THE WHITE COAT. ASDS MEMBERS GO LIVE ON @ASDSSKINMD INSTAGRAM FOR A BROADCAST WITH THE CONVERSATION TARGETED FOR CONSUMERS / PATIENTSCONSUMER SURVEY ON COSMETIC DERMATOLOGIC PROCEDURESTHE 2021 ASDS CONSUMER SURVEY ON COSMETIC DERMATOLOGIC PROCEDURES INDICATES DERMATOLOGISTS CONTINUE TO RANK AS THE NUMBER ONE INFLUENCER AMONG 16 FACTORS THAT IMPACT CONSUMERS' DECISIONS TO HAVE A COSMETIC PROCEDURE. AFTER A PAUSED DUE TO THE PANDEMIC'S IMPACT ON ACCESS TO COSMETIC PROCEDURES, DATA WAS OBTAINED THROUGH A BLIND ONLINE SURVEY CONDUCTED FROM OCT. 20, 2021, TO NOV. 9, 2021, VIA A WEB BASED PURESPECTRUM MARKET RESEARCH SERVICE. THE SURVEY RECEIVED 3,527 RESPONSES.MEMBER COMMUNITY - ASDS CONNECTASDS CONNECT IS THE SOCIETY'S DIGITAL COMMUNITY IS A MEMBER'S GO-TO PLACE TO NETWORK, SHARE INSIGHTS AND EXPERIENCE AND GAIN KNOWLEDGE FROM FELLOW ASDS COLLEAGUES. THE ASDS DIGITAL COMMUNITY WORK GROUP SET GOALS, METRICS AND STRATEGIC TACTICS TO CONTINUE THEIR CHARGE OF DEVELOPING STRATEGIES TO INCREASE MEMBER PARTICIPATION ON THE ASDS DIGITAL COMMUNITY PLATFORM. THE TARGETED GOALS FOR 2022 ALIGN WITH THE SOCIETY'S STRATEGIC GOALS AND ARE TO INCREASE MEMBERSHIP ENROLLMENT THAT AGREE TO THE CONNECT TERMS &amp; CONDITIONS FROM 1,623 TO 2,000, INCREASE THE NUMBER OF DISCUSSION POSTS FROM 801 TO 1,200 AND INCREASE MEMBER ENGAGEMENT BY MEASURING TOTAL NUMBER OF REPLIES TO DISCUSSION POSTS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>158855</ExpenseAmt>
        <RevenueAmt>237663</RevenueAmt>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>158855</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcRevenueAmt>237663</TotalOtherProgSrvcRevenueAmt>
      <TotalProgramServiceExpensesAmt>3626708</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">0</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>1</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>1</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="RetDoc1043400001">1</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">1</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>223</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>24</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>1</Form990TFiledInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>15</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>15</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>0</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>BETTY SARATA</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>8479560900</PhoneNum>
        <USAddress>
          <AddressLine1Txt>1933 N MEACHAM ROAD SUITE 650</AddressLine1Txt>
          <CityNm>SCHAUMBURG</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60173</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>VINCE BERTUCCI MD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SETH MATARASSO MD</PersonNm>
        <TitleTxt>PRESIDENT ELECT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KAVITA MARIWALLA MD</PersonNm>
        <TitleTxt>VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANTHONY M ROSSI MD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEIRDRE HOOPER MD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SUE ELLEN COX MD</PersonNm>
        <TitleTxt>IMMEDIATE PAST PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNA A BAR MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KYLE COLEMAN MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NAZANIN A SAEDI MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DIVYA SRIVASTAVA MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>OMAR A IBRAHIMI MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ERIC F BERNSTEIN MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KISHWER S NEHAL MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRYSALYNE SCHMULTS MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CYNDI J YAG-HOWARD MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KATHERINE J DUERDOTH CAE</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>26.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>14.00</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>326105</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>44966</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BETTY A SARATA</PersonNm>
        <TitleTxt>DIRECTOR OF FINANCE AND AD</TitleTxt>
        <AverageHoursPerWeekRt>18.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>22.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>146612</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>33662</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TARA AZZANO</PersonNm>
        <TitleTxt>DIRECTOR OF DEVELOPMENT AN</TitleTxt>
        <AverageHoursPerWeekRt>20.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>156942</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>18427</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAIMEY WILMAN</PersonNm>
        <TitleTxt>DIRECTOR OF PR, COMMUNICAT</TitleTxt>
        <AverageHoursPerWeekRt>36.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>4.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>136274</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>9168</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KRISTIN HELLQUIST</PersonNm>
        <TitleTxt>DIRECTOR OF ADVOCACY AND P</TitleTxt>
        <AverageHoursPerWeekRt>0.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>36.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>135646</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>17149</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MOIRA TWITTY</PersonNm>
        <TitleTxt>DIRECTOR OF EDUCATION AND</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>146543</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>9010</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>1048122</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>132382</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>6</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>WILLIAM P COLEMAN III MD</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>4425 CONLIN STREET</AddressLine1Txt>
            <CityNm>METAIRIE</CityNm>
            <StateAbbreviationCd>LA</StateAbbreviationCd>
            <ZIPCd>70006</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>JOURNAL EDITOR</ServicesDesc>
        <CompensationAmt>175484</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>2127047</AllOtherContributionsAmt>
      <TotalContributionsAmt>2127047</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>ANNUAL MEETING</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1870506</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1870506</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>933861</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>933861</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SEMINARS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>330012</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>330012</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>ADVERTISING</Desc>
        <BusinessCd>541800</BusinessCd>
        <TotalRevenueColumnAmt>43134</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>43134</UnrelatedBusinessRevenueAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>INFORMATION PAMPHLETS</Desc>
        <BusinessCd>513190</BusinessCd>
        <TotalRevenueColumnAmt>16213</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>16213</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>3193726</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>548454</TotalRevenueColumnAmt>
        <ExclusionAmt>548454</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>674269</TotalRevenueColumnAmt>
        <ExclusionAmt>674269</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>1444571</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>1380014</SecuritiesAmt>
        <OtherAmt>1384432</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>64557</SecuritiesAmt>
        <OtherAmt>-1384432</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-1319875</TotalRevenueColumnAmt>
        <ExclusionAmt>-1319875</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>PUBLICATION EDITOR FEES</Desc>
        <BusinessCd>513120</BusinessCd>
        <TotalRevenueColumnAmt>187450</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>187450</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>34000</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>34000</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>221450</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>5445071</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3372042</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>43134</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>-97152</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>232500</TotalAmt>
        <ProgramServicesAmt>232500</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>696455</TotalAmt>
        <ProgramServicesAmt>366131</ProgramServicesAmt>
        <ManagementAndGeneralAmt>240607</ManagementAndGeneralAmt>
        <FundraisingAmt>89717</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>663979</TotalAmt>
        <ProgramServicesAmt>473838</ProgramServicesAmt>
        <ManagementAndGeneralAmt>182539</ManagementAndGeneralAmt>
        <FundraisingAmt>7602</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>56870</TotalAmt>
        <ProgramServicesAmt>35113</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17689</ManagementAndGeneralAmt>
        <FundraisingAmt>4068</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>177963</TotalAmt>
        <ProgramServicesAmt>109880</ProgramServicesAmt>
        <ManagementAndGeneralAmt>55352</ManagementAndGeneralAmt>
        <FundraisingAmt>12731</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>116184</TotalAmt>
        <ProgramServicesAmt>71735</ProgramServicesAmt>
        <ManagementAndGeneralAmt>36138</ManagementAndGeneralAmt>
        <FundraisingAmt>8311</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>22204</TotalAmt>
        <ProgramServicesAmt>2204</ProgramServicesAmt>
        <ManagementAndGeneralAmt>20000</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>22586</TotalAmt>
        <ManagementAndGeneralAmt>22586</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>275892</TotalAmt>
        <ProgramServicesAmt>176664</ProgramServicesAmt>
        <ManagementAndGeneralAmt>68421</ManagementAndGeneralAmt>
        <FundraisingAmt>30807</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>38138</TotalAmt>
        <ProgramServicesAmt>38138</ProgramServicesAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>57990</TotalAmt>
        <ProgramServicesAmt>27412</ProgramServicesAmt>
        <ManagementAndGeneralAmt>24455</ManagementAndGeneralAmt>
        <FundraisingAmt>6123</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>198214</TotalAmt>
        <ProgramServicesAmt>102821</ProgramServicesAmt>
        <ManagementAndGeneralAmt>95393</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>241565</TotalAmt>
        <ProgramServicesAmt>171869</ProgramServicesAmt>
        <ManagementAndGeneralAmt>53005</ManagementAndGeneralAmt>
        <FundraisingAmt>16691</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>198502</TotalAmt>
        <ProgramServicesAmt>35518</ProgramServicesAmt>
        <ManagementAndGeneralAmt>63793</ManagementAndGeneralAmt>
        <FundraisingAmt>99191</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>1504144</TotalAmt>
        <ProgramServicesAmt>1060875</ProgramServicesAmt>
        <ManagementAndGeneralAmt>103461</ManagementAndGeneralAmt>
        <FundraisingAmt>339808</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>37022</TotalAmt>
        <ProgramServicesAmt>22860</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11514</ManagementAndGeneralAmt>
        <FundraisingAmt>2648</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>63727</TotalAmt>
        <ProgramServicesAmt>50025</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11140</ManagementAndGeneralAmt>
        <FundraisingAmt>2562</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>DUES AND SUBSCRIPTIONS</Desc>
        <TotalAmt>269792</TotalAmt>
        <ProgramServicesAmt>267457</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1945</ManagementAndGeneralAmt>
        <FundraisingAmt>390</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PRODUCTION COSTS</Desc>
        <TotalAmt>250300</TotalAmt>
        <ProgramServicesAmt>213532</ProgramServicesAmt>
        <ManagementAndGeneralAmt>36768</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CREDIT CARD PROCESSING</Desc>
        <TotalAmt>135127</TotalAmt>
        <ProgramServicesAmt>121751</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10875</ManagementAndGeneralAmt>
        <FundraisingAmt>2501</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>25832</TotalAmt>
        <ProgramServicesAmt>7822</ProgramServicesAmt>
        <ManagementAndGeneralAmt>23175</ManagementAndGeneralAmt>
        <FundraisingAmt>-5165</FundraisingAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>32281</TotalAmt>
        <ProgramServicesAmt>38563</ProgramServicesAmt>
        <ManagementAndGeneralAmt>-9622</ManagementAndGeneralAmt>
        <FundraisingAmt>3340</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>5317267</TotalAmt>
        <ProgramServicesAmt>3626708</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1069234</ManagementAndGeneralAmt>
        <FundraisingAmt>621325</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1</BOYAmt>
        <EOYAmt>1</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>3503227</BOYAmt>
        <EOYAmt>3531557</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>109637</BOYAmt>
        <EOYAmt>163260</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>203364</BOYAmt>
        <EOYAmt>47970</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>255901</BOYAmt>
        <EOYAmt>319848</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>1002808</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>941552</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>70979</BOYAmt>
        <EOYAmt>61256</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>11159475</BOYAmt>
        <EOYAmt>9463785</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>1333081</BOYAmt>
        <EOYAmt>23754</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>16635665</BOYAmt>
        <EOYAmt>13611431</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>976567</BOYAmt>
        <EOYAmt>429087</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>61312</BOYAmt>
        <EOYAmt>62750</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>732124</BOYAmt>
        <EOYAmt>596865</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>400972</BOYAmt>
        <EOYAmt>126909</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>2170975</BOYAmt>
        <EOYAmt>1215611</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>12972338</BOYAmt>
        <EOYAmt>11021742</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>1492352</BOYAmt>
        <EOYAmt>1374078</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>14464690</BOYAmt>
        <EOYAmt>12395820</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>16635665</BOYAmt>
        <EOYAmt>13611431</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>127804</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-2121600</NetUnrlzdGainsLossesInvstAmt>
      <InvestmentExpenseAmt>-75074</InvestmentExpenseAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>3325562</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2957636</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2583659</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3555231</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3407133</CurrentTaxYearAmt>
        <TotalAmt>15829221</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>3325562</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2957636</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2583659</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3555231</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3407133</CurrentTaxYearAmt>
        <TotalAmt>15829221</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>3899392</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>11929829</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>963324</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1067521</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>968318</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1289847</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1287280</CurrentTaxYearAmt>
        <TotalAmt>5576290</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <CurrentTaxYearMinus4YearsAmt>6266</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>7095</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>17743</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>21590</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>43134</CurrentTaxYearAmt>
        <TotalAmt>95828</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>208839</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>243020</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>238100</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>235900</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>221450</CurrentTaxYearAmt>
        <TotalAmt>1147309</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>22648648</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>1938956</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.52670</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.53530</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>549227</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-29420</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>-10496</OtherExpendituresAmt>
        <EndYearBalanceAmt>509311</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>497209</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>52472</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>454</OtherExpendituresAmt>
        <EndYearBalanceAmt>549227</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>398464</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>101925</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>3180</OtherExpendituresAmt>
        <EndYearBalanceAmt>497209</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>398464</BeginningYearBalanceAmt>
        <EndYearBalanceAmt>398464</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>421205</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-22741</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>398464</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>1002808</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>941552</DepreciationAmt>
        <BookValueAmt>61256</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>61256</TotalBookValueLandBuildingsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>DUE TO ASDSA</Desc>
        <Amt>102005</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>OPERATING LEASE LIABILITY</Desc>
        <Amt>24904</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>126909</TotalLiabilityAmt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY'S ENDOWMENT FUND CONSISTS OF FUNDS ESTABLISHED TO PROVIDE FOR CERTAIN TRAVEL RELATED COSTS FOR MENTORSHIP AND TABLE-SIDE EXCHANGE BETWEEN INTERNATIONAL DERMATOLOGIC SURGEONS AND THOSE PRACTICING IN THE UNITED STATES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>PRECEPTORSHIP EXPENSE REIMBURSEMENT</GrantTypeTxt>
        <RecipientCnt>23</RecipientCnt>
        <CashGrantAmt>23500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>RESEARCH GRANTS</GrantTypeTxt>
        <RecipientCnt>8</RecipientCnt>
        <CashGrantAmt>33500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>ANNUAL MEETING TRAVEL GRANTS</GrantTypeTxt>
        <RecipientCnt>232</RecipientCnt>
        <CashGrantAmt>174000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>FIELD OUTREACH GRANT</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>CERTAIN GRANTEES ARE REQUIRED TO ISSUE A BUDGET TO THE SOCIETY ON HOW THE FUNDS WILL BE SPENT. THEY ARE ALSO REQUIRED TO GIVE A SIX MONTH AND FINAL REPORT AS TO THE RESULTS OF THE RESEARCH. THIS REPORT IS GIVEN AT THE ANNUAL MEETING AND ALSO PUBLISHED IN THE JOURNAL. ANY UNUSED FUNDS ARE SENT BACK TO THE SOCIETY.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KATHERINE J DUERDOTH CAE</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>296105</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>30000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>19566</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>25400</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>371071</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BETTY A SARATA</PersonNm>
        <TitleTxt>DIRECTOR OF FINANCE AND AD</TitleTxt>
        <BaseCompensationFilingOrgAmt>146612</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>8797</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>24865</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>180274</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>TARA AZZANO</PersonNm>
        <TitleTxt>DIRECTOR OF DEVELOPMENT AN</TitleTxt>
        <BaseCompensationFilingOrgAmt>156942</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>9417</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>9010</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>175369</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MOIRA TWITTY</PersonNm>
        <TitleTxt>DIRECTOR OF EDUCATION AND</TitleTxt>
        <BaseCompensationFilingOrgAmt>146543</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>9010</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>155553</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KRISTIN HELLQUIST</PersonNm>
        <TitleTxt>DIRECTOR OF ADVOCACY AND P</TitleTxt>
        <BaseCompensationFilingOrgAmt>135646</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>8139</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>9010</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>152795</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>SOLUTIONS FOR ASSOCIATION MANAGEMENT INC</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>WHOLLY OWNED SUBSIDIARY</RelationshipDescriptionTxt>
        <TransactionAmt>0</TransactionAmt>
        <TransactionDesc>ADVANCE TO SUBSIDIARY.</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>(C) AMOUNT OF TRANSACTION</FormAndLineReferenceDesc>
        <ExplanationTxt>SOLUTIONS FOR ASSOCIATION MANAGEMENT, INC. (SAMI) WAS ESTABLISHED TO PROVIDE SPECIALIZED MANAGEMENT SERVICES FOR SMALL TO MEDIUM SIZED MEDICAL NONPROFITS. DUE TO DECREASED CLIENTS AND A SHRINKING BUSINESS ENVIRONMENT, MADE MORE DIFFICULT BY THE PANDEMIC, THE SOCIETY'S BOARD OF DIRECTORS MADE THE DETERMINATION TO CEASE THE OPERATIONS OF SAMI. AS OF 12/31/22, SAMI IS TERMINATED AND DISSOLVED.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS ONE CLASS OF MEMBERSHIP. THE MEMBERS ELECT THE BOARD OF DIRECTORS AS WELL AS THE VICE PRESIDENT AND TREASURER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MEMBERS ELECT THE BOARD OF DIRECTORS AS WELL AS THE VICE PRESIDENT AND TREASURER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 IS REVIEWED AND APPROVED BY MANAGEMENT BEFORE BEING FILED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>VERBAL ACKNOWLEDGEMENT IS RECOGNIZED AT THE BOARD OF DIRECTOR MEETINGS. IN ADDITION, ALL DIRECTORS ARE REQUIRED TO MAKE CHANGES (IF ANY) TO THEIR CONFLICT OF INTEREST ACKNOWLEDGEMENT AT EVERY BOARD OF DIRECTORS MEETING AND SIGN THE CONFLICT OF INTEREST POLICY PRESENTED TO THEM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS PROCESS OCCURS ANNUALLY. THREE REPRESENTATIVES OF THE BOARD OF DIRECTORS COMPLETE THE EXECUTIVE DIRECTORS'S EVALUATION. THE BOARD OF DIRECTORS ALSO USES INDUSTRY DATA ON SALARIES FOR EXECUTIVE DIRECTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART III, QUESTION 4B (CONTINUATION OF PROGRAM SERVICE ACCOMPLISHMENTS)</FormAndLineReferenceDesc>
        <ExplanationTxt>EDUCATIONAL EXCHANGE VIRTUAL PROFESSOR PROGRAM SIX VIRTUAL PROFESSOR PROGRAM WEBINARS FOR RESIDENTS AND FELLOWS-IN-TRAINING HAVE BEEN HELD OR ARE SCHEDULED FOR 2022: - HYPERPIGMENTATION - JANUARY 25 @ 7PM CENTRAL SEEMAL DESAI, MD 49 REGISTRANTS, 24 LIVE ATTENDEES - DERMATOLOGIC ONCOLOGY - FEBRUARY 22 @ 7PM CENTRAL MARC BROWN, MD 60 REGISTRANTS, 24 LIVE ATTENDEES - NEUROMODULATORS UPDATE - APRIL 26 @ 7PM CENTRAL DAVID OZOG, MD 65 REGISTRANTS, 28 LIVE ATTENDEES - PERI-OPERATIVE CONSIDERATIONS - MAY 24 @ 7PM CENTRAL DIVYA SRIVASTAVA, MD 47 REGISTRANTS, 21 LIVE ATTENDEES - DERMAL FILLERS UPDATE - SEPTEMBER 20 @ 7PM CENTRAL JOELY KAUFMAN, MD; 32 REGISTERED; 32 LIVE ATTENDEES - SURGICAL COMPLICATIONS - OCTOBER 25 @ 7PM CENTRAL DIVYA SRIVASTAVA, MD; 27 REGISTERED EDUCATIONAL COURSES IN 2015, ASDS STARTED THE PREMIER ANNUAL RESIDENT COSMETIC SYMPOSIUM, A 3-DAY INTENSIVE DIVE INTO AESTHETIC PROCEDURES TO FILL A GAP IN RESIDENTS' COSMETIC TRAINING. OUR 2022 SYMPOSIUM WAS HELD THIS APRIL IN DALLAS AND SOLD OUT ONCE AGAIN WITH MORE THAN 100 RESIDENTS IN ATTENDANCE. THIS POPULAR COURSE OFFERS A UNIQUE OPPORTUNITY FOR BUILDING SOCIAL CONNECTIONS THROUGH BOTH FORMAL AND INFORMAL NETWORKING TIME. A NEW IN-PERSON EDUCATIONAL OFFERING THIS YEAR WAS THE "FACIAL ANATOMY: INJECTION AND DISSECTION COURSE" HELD IN NASHVILLE THIS PAST JUNE. THIS 1 AND A HALF-DAY INTENSIVE HANDS-ON TRAINING IMPROVED ATTENDEES' CLINICAL AND FUNCTIONAL KNOWLEDGE OF FACIAL ANATOMY FOR MINIMALLY INVASIVE INJECTION PROCEDURES WITH RENOWNED EXPERTS. ATTENDEES EXPERIENCED HIGH YIELD LECTURES AND LIVE DISSECTION DEMONSTRATIONS WITH CADAVER LABS. NEW IN 2022 WAS THE 360-DEGREE INJECTION TECHNIQUES AND STRATEGY LIVE COURSE WAS HELD IN SEPTEMBER IN CHICAGO. THIS FULL-CIRCLE COURSE WAS PROVIDED TO ALL SKILL LEVELS REVIEWING THE ESSENTIALS OF FACIAL ANATOMY, INJECTION PEARLS, STRATEGIES, TOOLS AND TECHNIQUES. ATTENDEES ENJOYED HIGH-YIELD LECTURES, PANEL DISCUSSIONS, REAL WORLD STUDIES AND LIVE PATIENT DEMONSTRATIONS. VIRTUAL EDUCATION VIRTUAL EDUCATION IS AN ONGOING NEED, AND WE CONTINUE TO EXPAND OUR ON-DEMAND DIGITAL RESOURCES THROUGH OUR LEARNING MANAGEMENT SYSTEM, ASDS LEARN. THIS YEAR WE REJUVENATED THE LOOK, FEEL AND NAVIGATION TO MAKE IT EASIER TO ACCESS LIVE AND ON-DEMAND EDUCATIONAL CONTENT. CONTENT IS NOW CATEGORIZED SO THAT YOU CAN QUICKLY FIND WHAT YOU NEED. ASDS PRODUCES A NUMBER OF DISTANCE LEARNING OPPORTUNITIES FOR ITS MEMBERS. THE FOLLOWING ARE CURRENTLY AVAILABLE ONLINE: 1 LEADERSHIP DEVELOPMENT SERIES PODCASTS 2 MENTORING FOR SUCCESS 3 HOLDING DIFFICULT CONVERSATIONS 4 HARNESSING THE BENEFITS OF DELEGATION 5 MANAGING CONFLICT 6 NEGOTIATING SKILLS 7 PLANNING &amp; WRITING PERSUASIVE PRESENTATIONS 8 MINI-MBA PART 1: SUCCESSFUL PRACTICE MANAGEMENT 9 MINI-MBA PART 2: SUCCESSFUL PRACTICE MARKETING 10 MANAGEMENT OF ACTINIC KERATOSIS, SQUAMOUS CELL CARCINOMA AND BASAL CELL CARCINOMA 11 MEDICAL TRIAGING &amp; TIPS FOR THE NURSE IN THE DERMATOLOGY PRACTICE 12 MINI-MBA PART 1: SUCCESSFUL PRACTICE MANAGEMENT 13 MINI-MBA PART 2: SUCCESSFUL PRACTICE MARKETING MOBILE APP: THE ASDS MEMBER APP IS AVAILABLE FOR BOTH APPLE AND ANDROID SYSTEMS. WHILE A LARGE PERCENTAGE OF THE APP FOCUSES ON THE ANNUAL MEETING, OUR MEMBERS ALSO CAN FIND INFORMATION ON EDUCATION, PRACTICE RESOURCES, MEDIA, MENTORSHIP PROGRAMS AND OTHER RESOURCES. SCHOLARSHIP PROGRAM FOR RESIDENTS: ASDS PROVIDED SCHOLARSHIPS FOR RESIDENTS TO ATTEND THE ANNUAL MEETING AND THE RESIDENT COSMETIC SYMPOSIUM. THIS MAKES IT EASIER AND MORE AFFORDABLE FOR THEM TO TAKE ADVANTAGE OF THESE EDUCATIONAL OPPORTUNITIES WHICH AUGMENT THEIR RESIDENCY TRAINING. THE SCHOLARSHIPS WERE FUNDED BY EXTERNAL SOURCES. DERMSURG FELLOWSHIP FINDER THE FELLOWSHIP FINDER PROVIDES RESIDENTS WITH A COMPREHENSIVE LIST OF MOHS, PROCEDURAL, COSMETIC AND LASER SURGERY-BASED DERMATOLOGY FELLOWSHIPS IN THE UNITED STATES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>5550 MEADOWBROOK DRIVE SUITE 120</AddressLine1Txt>
          <CityNm>ROLLING MEADOWS</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60008</ZIPCd>
        </USAddress>
        <PrimaryActivitiesTxt>TO PROMOTE THE INTERESTS OF DERMATOLOGIC SURGEONS</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)6</ExemptCodeSectionTxt>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <ControlledOrganizationInd>1</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>SOLUTIONS FOR ASSOCIATION MANAGEMENT INC</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <USAddress>
          <AddressLine1Txt>5550 MEADOWBROOK DRIVE SUITE 120</AddressLine1Txt>
          <CityNm>ROLLING MEADOWS</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60008</ZIPCd>
        </USAddress>
        <EIN>474419468</EIN>
        <PrimaryActivitiesTxt>ASSOCIATION MANAGEMENT</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <EntityTypeTxt>C</EntityTypeTxt>
        <OwnershipPct>1.00000</OwnershipPct>
        <ControlledOrganizationInd>1</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>0</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>0</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>1</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>1</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>0</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>0</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>451711</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>N</TransactionTypeTxt>
        <InvolvedAmt>189911</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SOLUTIONS FOR ASSOCIATION MANAGEMENT</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>394151</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SOLUTIONS FOR ASSOCIATION MANAGEMENT</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>N</TransactionTypeTxt>
        <InvolvedAmt>128593</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>
